Barings Global Short Duration High Yield Fund
NYSE:BGHBabson Capital Global Short Duration High Yield Fund is a closed ended fixed income mutual fund launched and managed by Barings LLC. The fund is co-managed by Babson Capital Global Advisors Limited. It invests in fixed income markets across the globe. The fund primarily invests in global high-yield bonds, loans, and other income-producing instruments that are, at the time of purchase, rated below Baa3 by Moody's Investors Service, Inc. or below BBB- by Standard & Poor's Rating Services. It seeks to invest in securities with a weighted average portfolio duration of three years or less. The fund employs bottom-up fundamental analysis to create its portfolio. It benchmarks the performance of its portfolio against the Bank of America/Merrill Lynch Global Non-Financial High Yield Constrained Index. The fund was formerly known as Babson Capital Global Short Duration High Yield Fund. Babson Capital Global Short Duration High Yield Fund was formed on October 25, 2012 and is domiciled in the United States.
Bolt Biotherapeutics
NASDAQ:BOLTBolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company's lead product candidate BDC-1001, which is in clinical development for the treatment of patients with human epidermal growth factor receptor 2- positive solid tumors, including breast, colorectal, endometrial, and gastroesophageal cancer. It is also developing BDC-3042, an agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer. The company has collaboration agreements with Toray Industries, Genmab A/S, Innovent Biologics, Inc., Bristol-Myers Squibb, and F. Hoffmann-La Roche Ltd; and license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City, California.
Canada Zinc Metals
CVE:CZXCanada Zinc Metals Corp. explores for and evaluates mineral resource properties in Canada. The company primarily explores for zinc-lead-silver base metals deposits. Its flagship property is the Akie property that consists of 46 mineral claims, which cover approximately 116 square kilometers, located in the Paleozoic Selwyn Basin, British Columbia. The company was formerly known as Mantle Resources Inc. and changed its name to Canada Zinc Metals Corp. in September 2008. Canada Zinc Metals Corp. was incorporated in 1988 and is headquartered in Vancouver, Canada.